Immunological and Autoimmune Disorders

recent-pharma-biotech-news-updates-gilead-vir-teladoc-tessera-dexcom-verve

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Gilead and Vir collaborate; Tessera scores $230M; Teladoc & Dexcom bring CGM Tech; Verve unveils lead candidate

Gilead and Vir Biotechnology Establish Clinical Collaboration Gilead Sciences, Inc. and Vir Biotechnology, Inc. announced that the companies have entered into a clinical collaboration to assess novel therapeutic combination strategies to develop a functional remedy for chronic hepatitis B virus (HBV). The companies schedule to initiate a Phase 2 trial assessing combination therapy for both treatment-experienced and treatment-naïve people living with HBV. The multi-arm trial will gauge various combinations of selgantolimod, Gilead's investigational TLR-8 agonist; VIR-2218, Vir's investigational small interfering ribonucleic acid (siRNA); and a commercially-...

Explore More...

Letter for AstraZeneca; Patheon on API plant; Sanofi, Regeneron’s Dupixent; Cerulean Pharma and Daré Bioscience enter into deal; Lilly on price hikes

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Immunological and Autoimmune Disorders

Gilead and Vir collaborate; Tessera scores $230M; Teladoc & Dexcom bring CGM Tech; Verve unveils lead candidate

Remicade’s launch; Endo cuts jobs; Analysts downgrade Pfizer; Corning $500M glass project

Gilead faces lawsuit; Herceptin stalled; Lilly revs up, Abemaciclib gets nod; Key Humira patent gets struck down

J&J nabs; Clovis plots Rubraca; Novartis scores EU approval; Seattle Genetics stops trials

Tesaro’s Zejula; Mylan on EpiPen; Ohio sues drugmakers; ATUM, Horizon Discovery Announce deal

Roche, Boehringer tout; Pfizer, Bristol-Myers got sued; FDA commissioner unveils; EpicGenetics expands

Merck’s Remicade; Sanofi, Regeneron set Kevzara; Novartis to sever; Teva puts women’s health

AZ’s benralizumab; Sanofi, Regeneron set; Nordisk preps; European countries offer

Humira’s patent; Teva laying off; GSK aims; Thermo acquires Patheon; J& J’s Invokana

More Views & Analysis

Merck sells biosimilars; AbbVie’s PARP; Pharma heads; Biogen looks to M&A

Samsung biosim nod sets; Lilly’s med hits; BioMarin sees pricing; Spinraza scores; Klick creates

Novartis gets CAR-T drug; Shire aims to block; Xeljanz stands; Payer snubs; Lawmakers pass a bill

Valeant’s asset-sale; Sanofi coughs up $19.8M; Sanofi’s Genzyme; India’s Alkem; GSK’s inhalers

Tesaro puts AstraZeneca; XELJANZ® receives; Innovus nabs; Alexion brings

Letter for AstraZeneca; Patheon on API plant; Sanofi, Regeneron’s Dupixent; Cerulean Pharma and Daré Bioscience enter into deal; Lilly on price hikes

Chronic Obstructive Pulmonary Disorder

AstraZeneca announces; Trivitron launches; BrainStorm Cell Therapeutics validates

Subscribe to our Updates

Daily

Weekly

Monthly